Right now, the PREVAIL clinical research study is enrolling adults with irritable bowel syndrome with diarrhea (IBS-D). Researchers are testing an investigational drug to learn if it may become a future treatment option.
You may qualify to participate in this study if you:
For qualified study participants, all study-related medication and care will be at no cost to you, and they will reimbursed for time and travel.
Right now, the PREVAIL clinical research study is enrolling adults with irritable bowel syndrome with diarrhea (IBS-D). Researchers are testing an investigational drug to learn if it may become a future treatment option.
People who volunteer and qualify for this study will participate for up to 19 weeks. Your health is very important to us and will be monitored throughout the study.
Are an adult aged 18 to 75 years
Have abdominal (belly) pain
Have frequent diarrhea
For qualified study participants, all study-related medication and care will be at no cost to you, and they will reimbursed for time and travel.